Name: Botulinum neurotoxin type A resistance: An emerging problem
Description: Long-term use and high doses of BoNT-A may lead to immunoresistance, limiting its future therapeutic benefit.

Botulinum neurotoxin A (BoNT-A), often referred to as ‘Botox’, is commonly used to treat medical conditions and increasingly in cosmetic procedures. However, long-term use and high doses of BoNT-A may lead to immunoresistance, limiting its future therapeutic benefit. A panel of experts including Dr Mary Dingley, Cosmetic Medicine Centre, Australia, is addressing this emerging issue. Its published recommendations offer a […]